Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Koninklijke Philips (PHG) Equity Average (2010 - 2012)

Koninklijke Philips' quarterly Equity Average came in at $4.5 billion in Q4 2012, up 19.39% year-on-year from $3.8 billion in Q1 2012, and up 11.72% quarter-over-quarter from $4.0 billion in Q3 2012.

Koninklijke Philips has reported Equity Average for 3 years, with the latest figure at $4.5 billion in Q4 2012.

  • For the quarter ending Q4 2012, Equity Average rose 19.39% year-over-year to $4.5 billion; the trailing twelve-month figure through Dec 2012 stood at $4.5 billion (up 19.39% YoY), and the FY2025 full-year result was $12.8 billion, down 0.73% from the prior year.
  • Equity Average for Q4 2012 stood at $4.5 billion, up from $4.0 billion in the prior quarter.
  • The five-year high for Equity Average was $6.8 billion in Q4 2010, with the low at $3.8 billion in Q4 2011.
  • Average Equity Average over 3 years is $4.6 billion, with a median of $4.0 billion recorded in 2012.
  • Year-over-year, Equity Average sank 44.42% in 2011 and grew 19.39% in 2012.
  • Tracing PHG's Equity Average over 3 years: stood at $6.8 billion in 2010, then sank by 44.42% to $3.8 billion in 2011, then increased by 19.39% to $4.5 billion in 2012.
  • The last three Equity Average figures came in at $4.5 billion (Q4 2012), $4.0 billion (Q3 2012), and $3.8 billion (Q4 2011), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 52.42 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.70 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 49.03 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 25.17 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 10.33 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.85 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.53 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 7.18 Bn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 12.69 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2012 4.51 Bn
Sep 30, 2012 4.03 Bn
Dec 31, 2011 3.78 Bn
Sep 30, 2011 4.00 Bn
Dec 31, 2010 6.79 Bn